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Hexanucleotide repeat expansion in an intron of Chromosome 9 open reading frame 72
(C9orf72) is the most common genetic cause of Amyotrophic Lateral Sclerosis (ALS) and
Frontotemporal Dementia (FTD). While functional haploinsufficiency of C9orf72 resulting
from the mutation may play a role in ALS/FTD, the actual cellular role of the protein has
been unclear. Recent findings have now shown that C9orf72 physically and functionally
interacts with multiple members of the Rab small GTPases family, consequently exerting
important influences on cellular membrane traffic and the process of autophagy. Loss
of C9orf72 impairs endocytosis in neuronal cell lines, and attenuated autophagosome
formation. Interestingly, C9orf72 could influence autophagy both as part of a Guanine
nucleotide exchange factor (GEF) complex, or as a Rab effector that facilitates transport
of the Unc-51-like Autophagy Activating Kinase 1 (Ulk1) autophagy initiation complex.
The cellular function of C9orf72 is discussed in the light of these recent findings.
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INTRODUCTION
Amyotrophic Lateral Sclerosis (ALS) is a progressive, fatal neurodegenerative disease affecting
motor neurons (Kiernan et al., 2011; Riva et al., 2016). About 10% of ALS cases have a hereditary
component, and more than 30 genes have now been identified for familial ALS (Iguchi et al., 2013;
Renton et al., 2014). Frontotemporal Dementia (FTD), on the other hand, is a clinical syndrome
of neuropsychiatric disorders associated with degeneration of the prefrontal and anterior temporal
cortex (Neary et al., 2005). These two seemingly clinically disparate neurodegenerative diseases
are genetically linked (Andersen, 2013; Bennion Callister and Pickering-Brown, 2014), and have
some common pathological features in terms of components of neuronal cytoplasmic inclusion,
or stress granules (Bentmann et al., 2013). Mutations in genes encoding RNA binding proteins
such as the TAR DNA binding protein of 43 kDa (TDP-43; Sreedharan et al., 2008) and Fused-
in-sarcoma (FUS; Kwiatkowski et al., 2009) causes familial ALS, and these mutant proteins are
found both in neuronal cytoplasmic inclusions of ALS patients and those with the most common
pathological phenotype of FTD, namely frontotemporal lobar degeneration (FTLD; Neumann
et al., 2006; Mackenzie et al., 2010). The clinically classified ALS and FTD may indeed be part of
a clinicopathological spectrum of diseases with overlapping etiology and pathology (Andersen,
2013; Thomas et al., 2013; Devenney et al., 2015). A prominent genetic linkage point between ALS
and FTD has been mapped to chromosome 9p (Vance et al., 2006; Pearson et al., 2011). In 2011,
an ALS-FTD causative mutation was identified in the form of a GGGGCC hexanucleotide repeat
expansion (from a typical 5–10 repeats to hundreds or more) in an intron of the gene Chromosome
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9 open reading frame 72 (C9orf72; DeJesus-Hernandez et al.,
2011; Renton et al., 2011). This mutation turns out to be the
most common cause of ALS/FTD in multiple cohorts worldwide
(DeJesus-Hernandez et al., 2011; Majounie et al., 2012; Rohrer
et al., 2015).
C9orf72 orthologs are found in most vertebrates and some
invertebrates like C. elegans, and phylogenetic analysis indicated
that it is likely present in the common ancestor of eukaryotes
(Levine et al., 2013a). In humans, C9orf72 has three alternatively
spliced transcripts, predicted to produce two polypeptide
isoforms (of 481 and 222 amino acid residues in length,
respectively). The most prominent feature of the protein is the
presence of a ‘‘Differentially expressed in normal and neoplastic
cells’’ (DENN) domain (Zhang et al., 2012; Levine et al., 2013a).
The DENN domain is a type of Longin/Roadblock domain
fold that are interacting platforms present in several classes
of proteins in the eukaryotic membrane trafficking machinery
(Levine et al., 2013b), and several DENN domain containing
proteins are verified Rab Guanine nucleotide exchange factors
(GEFs; Marat et al., 2011). This structural feature brings
to fore a possible function for this hitherto uncharacterized
pathological factor, namely, as modulators of Rab GTPase
activities.
Understanding the cellular role of C9orf72 may shed light
on ALS/FTD pathology, as an etiological consequence resulting
from a loss of function of the protein could be entertained.
The G-rich hexanucleotide repeat extension may contribute
to genetic haploinsufficiency by forming stable G-quadruplex
structures that disrupt transcription (Fratta et al., 2012) or
promote hypermethylation of the gene locus, thereby attenuating
C9orf72 expression (Xi et al., 2013). Loss or targeted silencing
of C9orf72 orthologs in C. elegans (Therrien et al., 2013) and
zebrafish (Ciura et al., 2013) have both resulted in morphological
and functional motor neuron deficits. Interestingly, however,
depletion of C9orf72 in mouse brain by about half via
intracerebroventricular injection of antisense oligonucleotides
did not result in any discernible motor or behavioral impairment
(Lagier-Tourenne et al., 2013), neither was any neuronal
defects observed in neural-specific mice knockouts (nestin-
Cre excision of floxed C9orf72, Koppers et al., 2015). In
fact, C9orf72-null mice developed normally and aged mice
do not suffer from motor neuron disease (O’Rourke et al.,
2016), but have other phenotypes that may well be relevant to
C9orf72’s recently deciphered roles in membrane trafficking and
autophagy.
Mutant C9orf72 may cause disease pathology through
several other mechanisms, which including gain-of-function
type toxicity resulting from dysregulation of RNA metabolism
and dipeptides generated by Repeat-associated non-ATG (RAN)
translation of the hexanucleotide expansion (Ash et al., 2013;
Mori et al., 2013; May et al., 2014; Mizielinska et al., 2014). These
mechanisms have been discussed in recent excellent reviews
(Mizielinska and Isaacs, 2014; Gitler and Tsuiji, 2016; Todd
and Petrucelli, 2016). The focus here shall instead be on recent
findings of how C9orf72 may influence cellular membrane traffic
and autophagy though Rab GTPases, and these are discussed
elaborated in the paragraphs below.
C9orf72’s INTERACTION WITH Rab
GTPases AND ITS INFLUENCE ON
MEMBRANE TRAFFICKING
C9orf72 has diverse subcellular distribution. It could be found
in both cytoplasmic and nuclear compartments (Farg et al.,
2014; Sellier et al., 2016), and is also secreted extracellularly,
with the latter likely occurring via some form of unconventional
exocytosis (Chua et al., 2012; Malhotra, 2013; Ponpuak et al.,
2015). Perhaps the only clue to its function is its DENN
domain (Levine et al., 2013a), which is shared by a number
of Rab GEFs (Marat et al., 2011; Zhang et al., 2012). Together
with the observation that C9orf72 decorates some intracellular
membranes, its DENN domain makes it likely that it may
modulate membrane traffic via regulating Rab activities. Atkin
and colleagues tested this directly by co-immunoprecipitation
andGFP-Trap in human andmouse neural cell lines and primary
neurons, and showed that Rabs 1, 5, 7 and 11 are amongst those
proteins associated with C9orf72 (Farg et al., 2014). C9orf72 also
exhibited a good degree of membrane co-localization with the
endocytic Rabs 7 and 11. An indication that C9orf72 may be
involved in endocytic transport was provided by the observation
that its silencing affected the endocytic trafficking of Shiga toxin
B and BDNF-bound TrkB to varying degrees (Farg et al., 2014).
However, a mechanistic understanding of C9orf72’s association
with these endocytic Rabs is still lacking, and whether their
guanine nucleotide binding status is indeed modified by C9orf72
remains unclear.
In another recent report, the role of C9orf72 functioning
as part of a GEF complex to a different set of Rabs has
been revealed (Sellier et al., 2016). The authors found, by
affinity tag purification and mass spectrometric sequencing,
a set of cellular associates of C9orf72, amongst which are
Rab8A and Rab39B. Two other interacting proteins are of
particular interest. One of these, WD-40 repeat 41 (WDR41),
is a WD-40 repeat domain containing protein with unknown
function (Stein et al., 2011). The other, Smith-Magenis Syndrome
chromosome region candidate 8 (SMCR8), is also a DENN
domain containing protein (Zhang et al., 2012). SMCR8 and
WDR41 directly interact with C9orf72, and these form a
tripartite complex which has prominent affinity for Rab8A
and Rab39B (and also interacts more weakly with a few
other Rabs). The complex also exhibits GEF activity that
could be measured in vitro towards both these Rabs, but
has no such activity towards another Rab that it does not
appear to interact with. This interaction between C9orf72
and SMCR8/WDR41 has also been reported by another
laboratory (Sullivan et al., 2016). Two observations made
with regards to the C9orf72-SMRC8-WDR41 complex are
noteworthy. Firstly, the interaction between the complex and
the Rabs are mostly dependent on SMRC8, which on its own
could associate with several Rabs. However, when bound to
WDR41 and C9orf72, its affinity is more prominent towards
Rab8A and Rab39B. Secondly, recombinant C9orf72 alone
has little or no GEF activity towards these Rabs, and it
appears to act as such only in complex with SMCR8 and
WDR1.
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 October 2016 | Volume 10 | Article 228
Tang C9orf72’s Modulation of Membrane Traffic and Autophagy
Does the new C9orf72-containing complex and their GEF
activity towards Rab8A and Rab39B inform us of C9orf72’s role
in membrane trafficking? Rab8A is an ubiquitously expressed
Rab with a well-known role in modulating polarized plasma
membrane transport in neurons (Huber et al., 1993) and non-
neuronal (Peränen et al., 1996) cells. It is apparently critical
for transport to the primary cilium (Yoshimura et al., 2007)
and is also known to regulate neuronal trafficking and dendritic
transport of both the ionotrophic AMPA receptor (Brown et al.,
2007) and metabotropic glutamate receptor (Esseltine et al.,
2012). Rab39B, on the other hand, is a brain-enriched Rab whose
mutations have been implicated in X-linked intellectual and
developmental disability (Giannandrea et al., 2010; Andersen
et al., 2014) and early-onset Parkinson’s disease (PD; Wilson
et al., 2014; Lesage et al., 2015; Mata et al., 2015). Reminiscent
of Rab8A, Rab39B has also been recently shown to specifically
regulate dendritic trafficking of AMPA receptor subunit GluA2
through its effector Protein interacting with C kinase 1 (PICK1;
Mignogna et al., 2015). Although it remains to be investigated,
it is conceivable that the C9orf72-containing GEF complex has
a role in dendritic trafficking of glutamate receptors and other
cargos.
C9orf72’s MODULATION OF AUTOPHAGY
THROUGH ITS INTERACTION WITH Rab
GTPases
The process of macroautophagy intersects with vesicular
membrane trafficking through Rab GTPases (Chua et al., 2011;
Ao et al., 2014; Szatmári and Sass, 2014), and C9orf72’s
interaction with Rabs indicate that it could also modulate
autophagic flow, a critical disease modifying process in
many neurodegenerative diseases that result from impaired
clearance of toxic protein/RNA aggregates (Jain and Ganesh,
2016). ALS/FTD are likewise characterized by impairment
of aggrephagy, the autophagosome mediated clearance of
ubiquitinated proteins (Thomas et al., 2013). In this regard,
C9orf72 was indeed shown to localize to autophagosome-like
structures that were positive for the autophagosome marker
Microtubule-associated protein 1A/1B-light chain 3 (LC3; Farg
et al., 2014). Sellier et al. (2016) have now showed that silencing
of C9orf72 expression in neurons attenuated the formation
of mTOR inhibitor-induced LC3B-positive autophagosomes.
A reduction in C9orf72 expression also promoted TDP-43
aggregation, and synergizes with Ataxin-2 intermediate-length
polyglutamine expansions (polyQ), a known genetic risk of ALS
(Bonini and Gitler, 2011; Wang et al., 2014), in promoting
neuronal death. A number of the C9orf72-associating proteins
identified by Sellier et al. (2016) have established connections
with autophagy. The most obvious of these is the autophagy
adaptor Sequestosome 1/p62, whose mutations have been
associated with ALS/FTD (Rubino et al., 2012). Another recent
report has shown that even an apparently conservative mutation
of p63, namely L341V, could be disease causing as the mutant
has significantly reduced binding affinity to LC3B (Goode et al.,
2016).
Pertaining to the Rabs, Rab8B, a close paralogs of Rab8A
that has overlapping functions with the latter in polarized
transport (Sato et al., 2014), is known to act through the
innate immunity regulator, TRAF family member-associated
NF-κB activator (TANK)-binding kinase 1 (TBK1; Weidberg
and Elazar, 2011), in autophagic elimination of mycobacteria in
macrophages (Pilli et al., 2012). The C9orf72-SMRC8-WDR41
complex does not appear to bind TBK1 directly, but was shown to
associate with TANK and other TBK1 adaptors. SMRC8 appears
to be a substrate of TBK1, and the latter’s phosphorylation of
SMRC8 is important for autophagy regulation. Phosphorylation-
dead mutants of SMCR8 were unable to rescue autophagy
defects resulting from its initial silencing, while phosphomimetic
mutants rescued defects resulting from TBK1 depletion. The
notion that SMCR8 phosphorylation is important for autophagy
induction was also attested to by the finding that it is
a substrate of the autophagy initiating kinase, Unc-51-like
kinase 1 (ULK1)/ATG1 (Noda and Fujioka, 2015; Xu et al.,
2015). Both the Rab8 isoforms could therefore be part of a
complex autophagy-modulating network that involves C9orf72
(see Figure 1). Interestingly though, overexpression of either
wild-type or constitutively active Rab8A did not rescue the defect
resulting from C9orf72 silencing, which suggest that the role of
both these Rabs in autophagy modulation is complex and non-
linear.
On the other hand, expression of a constitutively active
Rab39B did rescue the autophagy defect resulting from decreased
expression of C9orf72 (Sellier et al., 2016). As mentioned above,
Rab39B mutations were implicated in X-linked mental disability
with developmental defects and early-onset PD. Although shown
to be localized to Golgi-derived vesicles (Giannandrea et al.,
2010) and implicated in exocytic neuritogenesis and glutamate
receptor transport (Mignogna et al., 2015), the cellular function
of Rab39B is still largely unclear. A close paralog of Rab39B,
Rab39A, which is more ubiquitously expressed (but at much
lower levels in the brain than Rab39B) and known to be localized
to the late endocytic compartments (Becker et al., 2009; Seto
et al., 2011; Gambarte Tudela et al., 2015), has been previously
implicated in negative regulation of bacterial lipopolysaccharide-
induced autophagy in macrophages (Seto et al., 2013). Based on
the above, it does not appear that the role and activity of Rab39A
could be equated with the yet undefined activity of Rab39B in
autophagy in neurons. A vaguely relevant pathological feature
of PD resulting from Rab39B mutation is α-synuclein pathology,
which is relevant to autophagy impairment (Xilouri et al., 2016).
One plausible mode of action of Rab39B was suggested by the
authors (Ciura et al., 2016; Sellier et al., 2016). Activated by the
C9orf72-SMRC8-WDR41 GEF complex, Rab39B then engages
p62 to facilitate autophagic clearance of aggregated proteins, such
as Ataxin2 polyQ (Figure 1). However, more work is clearly
needed to decipher Rab39B’s roll in C9orf72 modulation of
autophagy.
Another recent finding has added to the complexity of
the picture, and implicated Rab1A in C9orf72’s autophagy
modulating function (Webster et al., 2016). The authors showed
by a proximity ligation assay and in vitro binding experiments
that C9orf72 interacts with all three members of the mammalian
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FIGURE 1 | A schematic diagram illustrating Chromosome 9 open reading frame 72 (C9orf72)’s recently deciphered interaction with various Rab
GTPases and its possible roles in membrane traffic and autophagy. C9orf72’s interaction with Rab1A and Rab8A may influence transport along the early and
post-Golgi exocytic pathways, respectively (black arrows). Rabs are depicted in red circles with their respective numbers. C9orf72’s functional interactions with the
Rabs described in the text are summarized (i to iv):
i. C9orf72’s interaction with Rab5, Rab7 and Rab39A may affect endocytic transport (green arrows).
ii. Acting as part of the Smith-Magenis Syndrome chromosome region candidate 8 (SMCR8) and WD-40 repeat 41 (WDR41) containing complex, C9orf72 is part of a
Guanine nucleotide exchange factor (GEF) complex which activates Rab39B (denoted as a change from green to red). Activated Rab39B’s subsequent
engagements of effectors molecules, such as p62, acts in autophagic clearance of ubiquitinated (Ub) substrates.
iii. On the other hand, C9orf72 could bridge the ULK1 autophagy initiating complex with Rab1A as an effector of the latter, thus delivering the ULK1 complex to the
phagophore.
iv. Autophagosomes may have multiple origins, including the membranes of the ER (blue dotted arrow), Golgi apparatus/TGN (black dotted arrow) and the
endosomal membranes (green dotted arrow), and C9orf72 may have a role to play in autophagosome generation from these compartments.
There is a complex crosstalk between the C9orf72 interacting proteins, for example ULK1 phosphorylates SMCR8, and the autophagy-initiating complex may thus
also promote downstream engagement of the autophagy scaffolding protein p62. LE/MVB, late endosome/multivesicular body; EE/RE, early endosome/recycling
endosome; Ap, autophagosome.
autophagy initiation complex, namely Ulk1, ATG13 and the FAK
family kinase-interacting protein of 200 kDa (FIP2000; Lin and
Hurley, 2016). Although C9orf72 does not affect ULK1 activation
resulting frommTOR inhibition, its loss appeared to affect ULK1
complex translocation to the phagophore by Rab1A (Lynch-
Day et al., 2010; Wang et al., 2013). Indeed, a yeast 2-hybrid
interaction screen identified Rab1A as an interacting partner
of C9orf72. C9orf72 binds preferentially to GTP-loaded active
Rab1A, and is thus a Rab1A effector, rather than regulator. As
a downstream effector of Rab1A, C9orf72 appears to mediate
the interaction between the GTPase and the Ulk1 complex,
acting as a translocation adaptor to bring these to the sites of
autophagosome formation.
C9orf72 AND Rabs IN A COMPLEX
NETWORK OF AUTOPHAGY MODULATION
Taking the above findings into consideration, C9orf72 thus has
apparent roles in modulating both cellular membrane traffic and
autophagy. If the C9orf72-containing GEF complex influenced
the function of Rab8A, it should regulate polarized dendritic
transport in neurons, and transport to neuronal primary cilia.
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Furthermore, depending on what it interacts with downstream
of Rab1A, it may have a role in the early exocytic pathway. On
the other hand, C9orf72’s co-immunoprecipitation with Rab5,
Rab7 and Rab11 points towards a role in endocytic transport and
recycling. This remains to be confirmed by further analysis.
Pertaining to autophagy, C9orf72 appears to have a dual
function, one in inducing autophagosome formation (acting
downstream of Rab1A; Webster et al., 2016), and another
in directing aggregated protein clearance through p62 (acting
upstream of Rab39B; Ciura et al., 2016; Sellier et al., 2016). There
are clear points of crosstalk between these two C9orf72-centric
nodes. Ulk1 phosphorylates and therefore modulates SMRC8’s
activity, and could potentially couple the activation of the
initiation complex and phagosome formation to a downstream
p62-mediated capture of autophagosomal cargo (see Figure 1).
This notion, while perhaps over-simplified, would explain the
autophagy defects associated with loss of C9orf72. It should
also be noted that the C9orf72-SMRC8-WDR41 GEF complex
may also regulate autophagy via other Rabs other than Rab39B.
Amongst the Rabs which showed a weaker association with the
complex, Rab12 is known to facilitate autophagosome trafficking
(Xu et al., 2015). Furthermore, close paralogs of Rab32 and
Rab33A, namely Rab38 (Hirota and Tanaka, 2009) and Rab33B
(Itoh et al., 2008), have all been implicated in some aspects of
autophagy.
How do these deciphered roles and activities in membrane
trafficking and autophagy in neuronal cells translate to its
role during development and ALS/FTD pathology? C9orf72−/−
mice have enlarged lymph nodes and spleens, with p62 and
LC3 levels clearly elevated in the C9orf72-deficient spleens
(O’Rourke et al., 2016). Cells of myeloid lineage, such
as macrophages and microglia, exhibited an age-dependent
pro-inflammatory response, with defects in endolysosomal
transport, lysosomal function and likely lysosomal degradation
of autophagosomes. These phenotypes are somewhat in line with
C9orf72’s modulation of exocytic/endocytic membrane traffic
and autophagic clearance, as discussed above. In a broad sense,
the anticipated loss of C9orf72 variant expression and function
in human mutations should have some contribution towards
the disease state in ALS/FTD. However, this may act ‘‘silently’’
alongside the more prominent and progressive pathological
features of RNA foci, and the more acutely toxic (Kanekura et al.,
2016), intercellular transmissible Gly-Ala dipeptide polymers
(Chang et al., 2016).
FUTURE PERSPECTIVES
In the paragraphs above, I have outlined and discussed
recent findings on C9orf72’s interactions with Rab GTPases
that point towards its role in the modulation of membrane
traffic and autophagy. Clearly we are only beginning to get a
glimpse of what C9orf72 does in cells, and more details of its
complex interactions with Rabs and their regulators/effectors
will likely be further revealed. Future investigations on the
cellular roles and functional consequences of the putative
interactions between C9orf72 and Rabs (including those
other than Rab1A, Rab8 and Rab39B) should be pursued.
Understanding of how the mutant hexanucleotide expansion
of C9orf72 affect neuronal membrane traffic and autophagy
would benefit from analyses using appropriate cellular and
in vivo models, including gene editing based knock-in. In
particular, whether and how the key processes of membrane
dynamics are perturbed by mutant C9orf72 in the relevant
neuron types affected in ALS/FTD should be of urgent
interest. New knowledge that we get from these studies
will undoubtedly facilitate interpretation of disease pathology,
and would hopefully in due course inform intervention
strategies.
NOTE ADDED IN PROOF
While the manuscript was in its final stage of review, Chen and
colleagues reported a C9ORF72/SMCR8/WDR41-containing
complex that also contain ATG101 (Yang, M., Liang, C.,
Swaminathan, K., Herrlinger, S., Lai, F., Shiekhattar, R., and
Chen, J.-F. (2016). A C9ORF72/SMCR8-containing complex
regulates ULK1 and plays a dual role in autophagy. Sci.
Adv. 2(9): e1601167). The C9orf72 complex has Rab39B GEF
activity, and also regulates Ulk1 levels as well as autophagic
activity.
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